KCM
Kingdon Capital Management’s Heron Therapeutics HRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-505,729
| Closed | -$9.36M | – | 54 |
|
2019
Q3 | $9.36M | Sell |
505,729
-325,092
| -39% | -$6.01M | 1.11% | 30 |
|
2019
Q2 | $15.4M | Sell |
830,821
-257,345
| -24% | -$4.78M | 1.52% | 19 |
|
2019
Q1 | $26.6M | Buy |
1,088,166
+27,396
| +3% | +$670K | 3.56% | 8 |
|
2018
Q4 | $27.5M | Buy |
1,060,770
+263,148
| +33% | +$6.83M | 4.15% | 3 |
|
2018
Q3 | $25.2M | Sell |
797,622
-11,231
| -1% | -$355K | 1.76% | 9 |
|
2018
Q2 | $31.4M | Sell |
808,853
-857,376
| -51% | -$33.3M | 2.19% | 5 |
|
2018
Q1 | $46M | Sell |
1,666,229
-63,428
| -4% | -$1.75M | 3.63% | 2 |
|
2017
Q4 | $31.3M | Sell |
1,729,657
-280,668
| -14% | -$5.08M | 2.02% | 6 |
|
2017
Q3 | $32.5M | Sell |
2,010,325
-299,279
| -13% | -$4.83M | 2.12% | 8 |
|
2017
Q2 | $32M | Sell |
2,309,604
-313,114
| -12% | -$4.34M | 2.19% | 9 |
|
2017
Q1 | $39.3M | Sell |
2,622,718
-190,443
| -7% | -$2.86M | 2.16% | 7 |
|
2016
Q4 | $36.9M | Buy |
2,813,161
+117,164
| +4% | +$1.53M | 1.78% | 11 |
|
2016
Q3 | $46.5M | Buy |
2,695,997
+1,784,890
| +196% | +$30.8M | 2.13% | 7 |
|
2016
Q2 | $16.4M | Buy |
911,107
+478,023
| +110% | +$8.63M | 0.9% | 25 |
|
2016
Q1 | $8.22M | Sell |
433,084
-435,945
| -50% | -$8.28M | 0.45% | 46 |
|
2015
Q4 | $23.2M | Buy |
869,029
+380,374
| +78% | +$10.2M | 1.13% | 15 |
|
2015
Q3 | $11.9M | Sell |
488,655
-333,762
| -41% | -$8.14M | 0.57% | 33 |
|
2015
Q2 | $25.6M | Buy |
822,417
+206,566
| +34% | +$6.44M | 1% | 19 |
|
2015
Q1 | $8.96M | Sell |
615,851
-240,000
| -28% | -$3.49M | 0.38% | 61 |
|
2014
Q4 | $8.61M | Buy |
855,851
+172,536
| +25% | +$1.74M | 0.37% | 65 |
|
2014
Q3 | $5.7M | Buy |
683,315
+45,000
| +7% | +$375K | 0.26% | 87 |
|
2014
Q2 | $7.86M | Buy |
638,315
+265,000
| +71% | +$3.26M | 0.3% | 80 |
|
2014
Q1 | $5.19M | Buy |
+373,315
| New | +$5.19M | 0.26% | 87 |
|